Kleiner Device Labs Awarded Patent for KG®2 Surge® flow-thru interbody system
INCLINE VILLAGE, Nev., Oct. 9, 2023 /PRNewswire/ -- Kleiner Device Labs today announced that it was recently awarded a U.S. patent for its new KG®2 Surge® flow-thru interbody system.
- INCLINE VILLAGE, Nev., Oct. 9, 2023 /PRNewswire/ -- Kleiner Device Labs today announced that it was recently awarded a U.S. patent for its new KG®2 Surge® flow-thru interbody system.
- This adds to the company's growing global portfolio of 35 issued patents and other intellectual property for spinal surgical technology developed by the company.
- "The technology that we developed with the KG2 Surge system simplifies the post-insertion delivery of a wide range of graft materials through the interbody and into the surrounding disc space," added CTO Alan Burkholder.
- The new KG2 Surge flow-thru interbody system was developed with the objectives of maximizing bone graft delivery to the prepared intervertebral disc space, and streamlining implant placement, positioning, and integration in the graft matrix.